Back
4D Molecular Therapeutics Vs. Minerva Neurosciences Industry Stock Comparison
Sell
44
FDMT
4D Molecular Therapeutics
Last Price:
25.59
Seasonality Move:
-0.46%
Sell
44
NERV
Minerva Neurosciences
Last Price:
2.62
Seasonality Move:
13.36%
Sell
44
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $25.75. The Score for FDMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Minerva Neurosciences (NERV)
is a Sell
Is Minerva Neurosciences a Buy, Sell or Hold?
- The current Minerva Neurosciences [NERV] share price is $2.48. The Score for NERV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- NERV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $25.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
NERV Stock Price Chart
What is Minerva Neurosciences's stock price today?
-
The Minerva Neurosciences share price today is $2.48
The current trend is relatively stagnant and NERV is experiencing slight selling pressure.
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 46.92 | Sell |
| Chaikin Money Flow: | -352330 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.49 - 26.73) | Buy |
| Bollinger Bands (100): | (20.6 - 30.16) | Buy |
NERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 44.43 | Sell |
| Chaikin Money Flow: | -5682 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.39 - 2.51) | Buy |
| Bollinger Bands (100): | (2.13 - 7.85) | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.11 | Sell |
| 20-day SMA: | 25.32 | Buy |
| 50-day SMA: | 27.99 | Sell |
| 200-day SMA: | 19.63 | Buy |
| 8-day EMA: | 25.78 | Sell |
| 20-day EMA: | 25.98 | Sell |
| 50-day EMA: | 26.38 | Sell |
| 200-day EMA: | 22 | Buy |
NERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.44 | Buy |
| 20-day SMA: | 2.45 | Buy |
| 50-day SMA: | 2.54 | Sell |
| 200-day SMA: | 5.93 | Sell |
| 8-day EMA: | 2.45 | Buy |
| 20-day EMA: | 2.48 | Buy |
| 50-day EMA: | 3.1 | Sell |
| 200-day EMA: | 5.05 | Sell |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.20 per share.
Minerva Neurosciences Earnings Growth & NERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.49 per share, and a decrease next year of $1.83 per share.
4D Molecular Therapeutics Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Minerva Neurosciences Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||